Autres langues

27/06/23 Bionik Laboratories Corp. Announces Executive Changes
21/06/23 Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023
21/06/23 Bionik Laboratories Corp. Auditor Raises 'Going Concern' Doubt
16/06/23 BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
16/06/23 Bionik Laboratories Expands Its Partnership with Lifepoint Health with the Installation of InMotion Robotic Devices at Four New Locations
16/06/23 Bionik Laboratories : Private Placement - Form 8-K
15/06/23 Bionik Laboratories Corp. Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations
13/06/23 Bionik Laboratories Corp. announced that it expects to receive $2 million in funding
24/05/23 Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida
23/05/23 BIONIK LABORATORIES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
04/05/23 BIONIK LABORATORIES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
26/04/23 BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
20/04/23 Bionik Laboratories Corp. announced that it has received $0.25 million in funding
24/03/23 Bionik Laboratories InMotion Robotic Devices on Display at the Korea International Medical and Hospital Equipment Show
23/02/23 BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
16/02/23 Bionik Laboratories Corp. announced that it has received $0.5 million in funding
09/02/23 Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results
08/02/23 BIONIK LABORATORIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
08/02/23 Bionik Laboratories Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
08/02/23 Earnings Flash (BNKL) BIONIK LABORATORIES Posts Q3 Revenue $575.1M
20/01/23 BIONIK LABORATORIES CORP. : Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
20/12/22 BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
17/11/22 BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
14/11/22 Bionik Laboratories Corp. announced that it has received $0.4 million in funding from Gd Holding
09/11/22 BIONIK LABORATORIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Aucun résultat pour cette recherche